therapy Archives - AudioMedica.com

Tagged: therapy

- in Oncology
- — 26 Feb, 2008
“Total Therapy” Possible Cure For Multiple Myeloma?

Bart Barlogie
Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
BART BARLOGIE, University of Arkansas, Little Rock
A treatment known as “total therapy” could cure many patients with multiple myeloma, conference-goers have just heard. The targeted
…
Read more
- in News · Oncology
- — 26 Feb, 2008
Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma

Martin Dreyling
Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
MARTIN DREYLING, University Hospital Grosshaden, Munich
Since the 1970s therapies for mantle cell lymphoma have greatly extended life, Martin Dreyling told conference delegates in Paris. He
…
Read more
- in Oncology
- — 25 Feb, 2008
Multiple Myeloma: Towards A Chronic Disease With Cure On The Horizon

Kenneth Anderson
Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
KENNETH ANDERSON, Dana-Farber Cancer Institute, Boston
Multiple myeloma may soon be considered a chronic disease with cure on the horizon, thanks to an array of novel
…
Read more
- in Oncology
- — 27 Jan, 2008
Gastrointestinal Cancers: Progress with Targeted Therapies

Robert Mayer
ROBERT MAYER, Dana-Farber Cancer Institute, Boston
One of the leading participants at the 2008 Gastrointestinal Cancers Symposium, Robert Mayer, gave Peter Goodwin his assessment of some of the emerging new therapies being announced, for colorectal, liver and
…
Read more
- in Oncology
- — 15 Dec, 2007
New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer

Jose Baselga
JOSE BASELGA, Vall d’Hebron Hospital, Barcelona
RAD001, a drug targeted at the mTor pathway, has been combined with letrozole in a randomised phase II trial in breast cancer. The investigators saw more responses in the experimental arm, and
…
Read more
- in Oncology
- — 10 Dec, 2007
Live Report from ASH:
Dasatinib Effective At Two Years’ Follow Up in Chronic Phase CML

Richard Stone
RICHARD STONE, Dana-Farber Cancer Institute, Boston
GEORGE CANELLOS, Dana-Farber Cancer Institute
New data shows that dasatinib is giving durable responses in patients with chronic phase chronic myeloid leukemia who have failed, or who cannot tolerate imatinib. So where
…
Read more
- in Public Health
- — 9 Dec, 2007
No Use Of Hydroxyurea In Country With Most Sickle Cell Anemia

Zakari Aliyu
REFERENCE: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
ZAKARI ALIYU, Howard University, Washington DC
Nigeria has the highest incidence of sickle cell anemia in the world, with over 150,000 children being born each year with
…
Read more
- in Cardiovascular
- — 6 Nov, 2007
Protective Cardiovascular Benefit for Women on HRT For Natural Menopause

George Sopko

Jennifer Mieres’; }?
REFERENCE: Abstract 3771, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
N Engl J Med 2007;357
GEORGE SOPKO, National Heart, Lung And Blood Institute, Bethesda, Maryland
COMMENT: JENNIFER MIERES, New York University
A
…
Read more
- in Cardiovascular
- — 6 Nov, 2007
TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent?

Gregg Stone
REFERENCE: Abstract 2357, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
GREGG STONE, Columbia University, New York
New light has been thrown on the use of thienopyridine therapy after percutaneous intervention using drug-eluting stents. Gregg Stone
…
Read more
- in Cardiovascular
- — 6 Nov, 2007
Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study

Uwe Zeymer
REFERENCE: Late Breaking Clinical Trials Session I, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
UWE ZEYMER, Herzzentrum Ludwigshafen, Germany
The glycoprotein 2B 3A antagonist eptifibatide has performed as well as standard abciximab therapy in patients
…
Read more
- in Cardiovascular
- — 5 Nov, 2007
Eptifibatide After PCI: Brief Infusion Is Just As Good

Anthony Fung
REFERENCE: Late Breaking Clinical Trials Session I, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
ANTHONY FUNG, University of British Columbia, Vancouver
Brief courses of antiplatelet therapy with the glycoprotein 2b 3a inhibitor are just as
…
Read more
- in Cardiovascular
- — 5 Nov, 2007
Stable Angina: Add PCI To Medical Therapy If Guided by SPECT-Detected Ischemia? COURAGE Nuclear Sub-Study Results
REFERENCE: Abstract: Late Breaking Clinical Trials, Session 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
LESLEE SHAW, Emory University, Atlanta
COMMENT: DANIEL JONES, AHA President, University of Mississippi, Jackson
Some patients with stable angina may be best …
Read more

Tagged: therapy

Sign up for AudioMedica.com news